About This Research Study
Atherosclerotic Cardiovascular Disease (ASCVD) is a serious condition caused by plaque buildup in the arteries. Over time, this buildup—a mix of fat, cholesterol, and other substances—makes the arteries narrow or even blocked, which can slow or stop blood flow. This can lead to serious health problems like a heart attack, stroke, or poor circulation.
Tekton Research is currently enrolling participants in a clinical trial evaluating an investigational medication intended to reduce the risk of major cardiovascular events. Qualified participants may be compensated up to $1,600 for time and travel.
Eligible participants…
- Must be 18+
- Must be diagnosed with or at risk for a first ASCVD event
- Must be on a stable dose of lipid-lowering therapies such as statins
- May receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.